African-American women less likely to benefit from HPV vaccines to avoid cervical cancer Two subtypes of human being papillomavirus prevented by vaccines are half as likely to be found in African-American women as in white ladies with precancerous cervical lesions, according to researchers at Duke Medicine. The results, presented on Oct. 28, 2013, at the 12th annual International Meeting on Frontiers in Cancers Prevention Study hosted by the American Association for Cancer Research, suggest that African-American women may be less likely to benefit from available HPV vaccines to prevent cervical cancer.Dark brown, M.D., lead writer of the declaration and immediate-past chair of the ATS Health Policy Committee, calls the record a ‘marching purchase’ that seeks to place the Society’s guiding objective, values and eyesight into operation. ‘The statement is essentially a plan in the years ahead as to how exactly to put our organizational ideals into practice,’ he said. The statement affirmatively claims that an ‘altruistic concern for sufferers should ultimately dictate ATS positions and activities’ with respect to patient usage of caution. ‘The ATS advocates strongly for universal usage of care for our residents, but in addition the treatment provided must meet accepted standards for quality.